
Amanda Marie Haney
Examiner (ID: 15654, Phone: (571)272-8668 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682 |
| Total Applications | 1025 |
| Issued Applications | 286 |
| Pending Applications | 134 |
| Abandoned Applications | 624 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14778739
[patent_doc_number] => 20190264267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => PHASING
[patent_app_type] => utility
[patent_app_number] => 16/320379
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320379 | PHASING | Jul 23, 2017 | Abandoned |
Array
(
[id] => 12159278
[patent_doc_number] => 20180030544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY'
[patent_app_type] => utility
[patent_app_number] => 15/651652
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 41334
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651652 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | Jul 16, 2017 | Abandoned |
Array
(
[id] => 14185935
[patent_doc_number] => 20190112672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => MITOCHONDRIAL DNA PROSTATE CANCER MARKER AND RELATED SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/306724
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306724
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306724 | Mitochondrial DNA prostate cancer marker and related systems and methods | Jun 1, 2017 | Issued |
Array
(
[id] => 15619465
[patent_doc_number] => 20200080137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => PORTABLE, LOW-COST PATHOGEN DETECTION AND STRAIN IDENTIFICATION PLATFORM
[patent_app_type] => utility
[patent_app_number] => 16/303937
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303937 | Portable, low-cost pathogen detection and strain identification platform | May 24, 2017 | Issued |
Array
(
[id] => 14716395
[patent_doc_number] => 20190249261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => Methods For Identifying Clonal Mutations And Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 16/300987
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300987 | Methods For Identifying Clonal Mutations And Treating Cancer | May 11, 2017 | Abandoned |
Array
(
[id] => 14231221
[patent_doc_number] => 20190127783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/096046
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -111
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096046 | COMPOSITIONS AND METHODS FOR THE DETECTION OF NUCLEIC ACIDS | Apr 26, 2017 | Pending |
Array
(
[id] => 14231217
[patent_doc_number] => 20190127781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => USE OF A MICROBIOME PROFILE TO DETECT LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/095334
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095334
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095334 | USE OF A MICROBIOME PROFILE TO DETECT LIVER DISEASE | Apr 19, 2017 | Abandoned |
Array
(
[id] => 11836734
[patent_doc_number] => 20170218452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Mutations Associated With Cystic Fibrosis'
[patent_app_type] => utility
[patent_app_number] => 15/490928
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 21384
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490928
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490928 | Mutations associated with cystic fibrosis | Apr 18, 2017 | Issued |
Array
(
[id] => 14102995
[patent_doc_number] => 20190093173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => PREDICTION OF HEPATOCELLULAR CARCINOMA ONSET AFTER CLEARANCE OF HEPATITIS C VIRUS
[patent_app_type] => utility
[patent_app_number] => 16/097954
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097954 | Prediction of hepatocellular carcinoma onset after clearance of hepatitis C virus | Mar 30, 2017 | Issued |
Array
(
[id] => 11823184
[patent_doc_number] => 20170212122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'MULTIPLEX TP53/CEN17/B CELL GENE-PROTEIN CO-DETECTION ASSAY AND UNIQUELY SPECIFIC PROBES FOR 19q12, INSR, ATM, DLEU2, TP53, AND 13q12'
[patent_app_type] => utility
[patent_app_number] => 15/472146
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 31618
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472146
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472146 | MULTIPLEX TP53/CEN17/B CELL GENE-PROTEIN CO-DETECTION ASSAY AND UNIQUELY SPECIFIC PROBES FOR 19q12, INSR, ATM, DLEU2, TP53, AND 13q12 | Mar 27, 2017 | Abandoned |
Array
(
[id] => 11956436
[patent_doc_number] => 20170260587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'SQSTM1 MUTATIONS IN AMYOTROPHIC LATERAL SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/470185
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11141
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470185
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470185 | SQSTM1 MUTATIONS IN AMYOTROPHIC LATERAL SCLEROSIS | Mar 26, 2017 | Abandoned |
Array
(
[id] => 14043935
[patent_doc_number] => 20190078074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => OBESITY RISK DIAGNOSIS KIT AND METHOD FOR ANALYZING RISK OF OBESITY ONSET
[patent_app_type] => utility
[patent_app_number] => 16/084969
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084969 | OBESITY RISK DIAGNOSIS KIT AND METHOD FOR ANALYZING RISK OF OBESITY ONSET | Mar 12, 2017 | Abandoned |
Array
(
[id] => 14231265
[patent_doc_number] => 20190127805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => GENE SIGNATURES FOR CANCER DETECTION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/084928
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084928 | GENE SIGNATURES FOR CANCER DETECTION AND TREATMENT | Mar 12, 2017 | Abandoned |
Array
(
[id] => 11715218
[patent_doc_number] => 20170183717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 15/454794
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17012
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15454794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/454794 | Detection of methicillin-resistant | Mar 8, 2017 | Issued |
Array
(
[id] => 14102979
[patent_doc_number] => 20190093165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => GENE SIGNATURE FOR THE PROGNOSIS OF DRY EYE DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/080702
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16080702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/080702 | GENE SIGNATURE FOR THE PROGNOSIS OF DRY EYE DISEASE | Feb 27, 2017 | Abandoned |
Array
(
[id] => 18825471
[patent_doc_number] => 11840742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Method for detecting active tuberculosis
[patent_app_type] => utility
[patent_app_number] => 16/079450
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 13
[patent_no_of_words] => 20518
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079450 | Method for detecting active tuberculosis | Feb 23, 2017 | Issued |
Array
(
[id] => 18355296
[patent_doc_number] => 11643688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Method for diagnosing mood disorder by using circadian rhythm
[patent_app_type] => utility
[patent_app_number] => 16/469760
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 5964
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 446
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469760 | Method for diagnosing mood disorder by using circadian rhythm | Feb 12, 2017 | Issued |
Array
(
[id] => 13906981
[patent_doc_number] => 20190042695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => METHOD FOR DIFFERENTIATING CONTRACTION OF ESOPHAGEAL BASALOID CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 16/074817
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074817 | METHOD FOR DIFFERENTIATING CONTRACTION OF ESOPHAGEAL BASALOID CARCINOMA | Feb 9, 2017 | Abandoned |
Array
(
[id] => 11691263
[patent_doc_number] => 20170166979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'PERSONALIZED TREATMENT OF CANCER USING FGFR INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/424900
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8531
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/424900 | PERSONALIZED TREATMENT OF CANCER USING FGFR INHIBITORS | Feb 5, 2017 | Abandoned |
Array
(
[id] => 16932856
[patent_doc_number] => 20210198745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs)
[patent_app_type] => utility
[patent_app_number] => 16/071231
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071231
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071231 | COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs) | Feb 2, 2017 | Abandoned |